Skip to content
Sunday, November 8, 2026
DailyLine

Zimbabwe Turns Down ‘Unbalanced’ US Health Aid Deal Over Data Apprehensions

Medical aid image
The proposed US funding was intended for initiatives for HIV/Aids treatment and prevention, TB, and malaria.

Zimbabwe has turned down a major US healthcare agreement valued at $367m (£272m) over five years because of Washington's request for confidential biological samples.

This move came to light after a official document dated December was leaked, revealing that President Emmerson Mnangagwa felt the deal was "lopsided".

A government representative has since stated that the US was requesting genetic material for scientific study and commercial gain but was unwilling to guarantee the resulting advantages from any future vaccines.

"We will now turn to the difficult and regrettable process of winding down our support in Zimbabwe," said US ambassador to Zimbabwe Pamela Tremont publicly.

Her embassy indicated the US had donated more than $1.9bn as health assistance to Zimbabwe over the last two decades.

A physicians' group in Zimbabwe has called for more negotiations to secure a deal suitable to all parties so the nation's critical HIV treatment initiative can proceed.

Broader Background

Zimbabwe's decision comes after a similar case in Kenya, where a high court halted a similar health funding agreement following legal challenges were raised about the security of citizens' health data.

Since returning to the presidency last year, US President Donald Trump has drastically cut foreign aid and shut down the key foreign aid agency.

The agency had administered aid for the American government, but Trump argued its spending was "wasteful" and his government was seeking government-to-government agreements to enhance openness and accountability.

As per reports, Sixteen nations in Africa have to date signed similar health pacts, constituting more than $18.3bn in committed funds.

Specifics of the Declined Deal

This assistance for Zimbabwe would have supported "combating HIV/Aids, tuberculosis, malaria, healthcare for mothers and children, and preparing for epidemics".

"We are confident this partnership might have yielded significant advantages for the people of Zimbabwe, particularly the 1.2 million currently receiving antiretroviral therapy through American-funded programmes," Tremont said.

However, government spokesperson Nick Mangwana maintained the proposed deal was "asymmetrical".

"Our nation was requested to provide its genetic material and health information over an extended period, with no equivalent promise of access to any scientific breakthroughs – such as new medicines or tests – that could result from that provided information," his statement read.

"Effectively, our nation would provide the raw materials for scientific discovery with no assurance that the end products would be available to our population should a new health crisis arise."

Sovereignty and Global Health

He also said that the American exit from the World Health Organization (WHO) and its pursuit of bilateral deals were undermining frameworks previously established via the international health agency.

The spokesperson gave as an example its Pandemic Benefit-Sharing framework designed to manage future global health emergencies.

"This mechanism is designed to guarantee that when a country contributes its data, the benefits – including vaccines and treatments – are shared equitably, not monopolised exclusively by those with the capability to create them."

Zimbabwe's reservations over the US deal "must not be interpreted as hostility towards the US," Mangwana stressed.

"We welcome ongoing dialogue with our US partners on how subsequent co-operation might be designed in a way that honours the independence and dignity of both nations."

Medical Community Reaction

A leading public health body expressed it acknowledged the official position, but urged that talks must proceed given that a large portion of the country's HIV programmes depended on external financing.

"If technical issues exist, including those relating to information security or implementation frameworks, these can frequently be addressed through technical clarification and negotiated safeguards," it said.

The situation underscores the ongoing debate between receiving vital international aid and protecting national sovereignty in an increasingly interconnected world.

Written by

Christopher Robertson

Award-winning journalist with over a decade of experience covering Capitol Hill and national politics.

DailyLine

Type to search articles.